Canada markets closed

Alliance Pharma plc (APH.L)

LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
102.80-0.20 (-0.19%)
At close: 04:35PM GMT

Alliance Pharma plc

Avonbridge House
Bath Road
Chippenham SN15 2BB
United Kingdom
44 12 4946 6966

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees250

Key Executives

NameTitlePayExercisedYear Born
Mr. Peter Jonathan ButterfieldCEO & Exec. Director612.03kN/A1976
Mr. Andrew Timothy FranklinCFO & Exec. Director349.23kN/A1966
Mr. Stephen KidnerChief Scientific Affairs & Operations OfficerN/AN/AN/A
Mr. Alex DugganChief Commercial & Corp. Devel. OfficerN/AN/AN/A
Ms. Janice TimberlakeChief People & Infrastructure OfficerN/AN/AN/A
Mr. Steve LobbHead of HydromolN/AN/AN/A
Mr. David HopeHead of Secondary CareN/AN/AN/A
Mr. Rajiv GhidiyalHead of APAC, EMEA & AmericasN/AN/AN/A
Mr. Karim HusnyHead of InternationalN/AN/AN/A
Chris DelafieldGlobal Marketing Head of Kelo-CoteN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.


Alliance Pharma plc operates as a pharmaceutical company in the United Kingdom, Republic of Ireland, Mainland Europe, the United States, and internationally. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. It owns or licenses the rights to approximately 80 pharmaceutical and consumer healthcare products. The company also offers medical devices, food supplements, and cosmetics. In addition, the company provides its products under the Kelo-Cote, Nizoral, MacuShield, Vamousse, Flamma Franchise, Aloclair, Hydromol, Forceval, Optiflo, Oxyplastine, Ashton & Parsons, and Ametop brand names. Alliance Pharma plc was founded in 1996 and is headquartered in Chippenham, the United Kingdom.

Corporate Governance

Alliance Pharma plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.